Cargando…
Severe Jaundice in a COVID-19 Patient–Virus or Drug?
Autores principales: | Jothimani, Dinesh, Vij, Mukul, Sanglodkar, Uday, Patil, Vaibhav, Sachan, Deepti, Narasimhan, Gomathy, Kaliamoorthy, Ilankumaran, Rela, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906515/ https://www.ncbi.nlm.nih.gov/pubmed/33654344 http://dx.doi.org/10.1016/j.jceh.2021.02.006 |
Ejemplares similares
-
COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020) -
Hemolytic events during therapeutic plasma exchange: Root cause analysis
por: Deepti, Sachan, et al.
Publicado: (2019) -
Pediatric metabolic liver diseases: Evolving role of liver transplantation
por: Menon, Jagadeesh, et al.
Publicado: (2021) -
Patient blood management in a patient with multiple red cell antibodies (anti-C, anti-e, and anti-K) undergoing liver transplant in South India: A team approach
por: Sachan, Deepti, et al.
Publicado: (2020) -
Outcome of Patients Awaiting Deceased Donor Liver Transplantation During COVID-19 Pandemic
por: Jothimani, Dinesh, et al.
Publicado: (2022)